EVOK

Evoke Pharma, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website evokepharma.com
Employees(FY) 4
ISIN US30049G2030

Performance

-2.11%

1W

-1.06%

1M

-31.62%

3M

-63.39%

6M

-55.73%

YTD

-74.31%

1Y

Profile

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Advanced Technical Analysis

Technical Analysis of EVOK 2024-05-10

Overview:

In analyzing the technical indicators for EVOK over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key factors, we aim to offer valuable insights and predictions for the upcoming days.

Trend Analysis:

...

See more ...

Recent News & Updates

2024-05-16 04:02
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference(Globenewswire)
2024-05-14 10:53
EVOK Stock Earnings: Evoke Pharma Beats EPS, Misses Revenue for Q1 2024(Investorplace)
2024-05-14 04:15
Evoke Pharma Reports First Quarter 2024 Financial Results(Globenewswire)
2024-04-16 20:30
Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications(Globenewswire)
2024-03-21 04:15
Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer(Globenewswire)
2024-03-15 01:58
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Earnings Call Transcript(Insidermonkey)
2024-03-14 18:56
Q4 2023 Evoke Pharma Inc Earnings Call(Yahoo Finance)
2024-03-14 04:05
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results(Globenewswire)
2024-03-07 03:10
Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024(Globenewswire)
2024-02-13 18:30
Evoke Pharma Announces Closing of $7.5 Million Public Offering(Globenewswire)
2024-02-08 18:30
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million(Globenewswire)
2023-11-29 23:16
Revolutionizing gastroparesis treatment: Evoke Pharma's CEO talks game-changing nasal spray(Yahoo Finance)
2023-11-26 19:30
Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI Patent(Globenewswire)
2023-11-13 19:30
United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI(Globenewswire)
2023-11-08 19:30
Evoke Pharma Reports Third Quarter 2023 Financial Results(Globenewswire)
2023-10-30 20:30
Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healthcare Costs for Patients Using GIMOTI Over Oral Metoclopramide Presented at the American College of Gastroenterology 2023(Globenewswire)
2023-10-22 18:30
7 Under-the-Radar Growth Stocks Ready to Make a Splash(Yahoo Finance)
2023-10-17 20:30
Evoke Pharma's Abstract Entitled Superiority of Nasal Spray Compared to Orally Administered Metoclopramide in Reducing Healthcare Costs in Treating Diabetic Gastroparesis Patients to Be Presented at The American College of Gastroenterology (ACG) 2023 Ann(Globenewswire)
2023-09-13 20:30
Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI®(Yahoo Finance)
2023-08-09 20:30
Evoke Pharma Reports Second Quarter 2023 Financial Results(Yahoo Finance)
2023-08-06 20:30
Evoke Pharma and EVERSANA Announce Abstract Acceptance at 2023 American Neurogastroenterology and Motility Society (ANMS) Meeting(Yahoo Finance)
2023-07-24 20:30
Evoke Pharma and EVERSANA Announce Abstract Selection for Plenary Oral Presentation at The American College of Gastroenterology (ACG) 2023 Annual Meeting(Yahoo Finance)
2023-06-13 20:30
Evoke Pharma to Host First Key Opinion Leader Webinar on Healthcare Resource Utilization Data Related to Gastroparesis and its Treatment(Yahoo Finance)
2023-05-15 04:05
Evoke Pharma Reports First Quarter 2023 Financial Results(Yahoo Finance)
2023-05-08 19:00
Real-World Data Presented by Evoke Pharma and EVERSANA at Digestive Disease Week 2023 Shows Gimoti® Meaningfully Reduces Utilization of Healthcare Resources(Yahoo Finance)
2023-05-03 20:30
Evoke Pharmas Real-World Healthcare Utilization Data Comparing GIMOTI® to Oral Metoclopramide to Be Presented at Digestive Disease Week (DDW) 2023(Yahoo Finance)
2023-04-30 20:30
New GIMOTI Patent Listed in FDA Orange Book(Yahoo Finance)
2023-04-19 20:30
United States Patent and Trademark Office (USPTO) Grants Evoke Pharma a Formulation Patent Covering GIMOTI(Yahoo Finance)
2023-04-05 20:30
Evoke Pharma Receives Notice of Allowance from USPTO for GIMOTI-Related Patent(Yahoo Finance)
2023-03-23 19:36
Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2022 Earnings Call Transcript(Yahoo Finance)

Page 1 of 4

previousnext